scholarly journals J-ALEX trial will crown alectinib as the standard choice for anaplastic lymphoma kinase positive untreated non-small cell lung cancer patients?

2018 ◽  
Vol 10 (1) ◽  
pp. 106-108 ◽  
Author(s):  
Cesare Gridelli ◽  
Francesca Casaluce ◽  
Assunta Sgambato ◽  
Giovanni Palazzolo ◽  
Paolo Maione
Sign in / Sign up

Export Citation Format

Share Document